An Unexpected Diagnosis of Second Primary Malignancy in a Breast Cancer Survivor: A Case Report
暂无分享,去创建一个
[1] G. Che,et al. Authors' Reply to Letter to the Editor Regarding the Article "Risk and Influencing Factors for Subsequent Primary Lung Cancer After Treatment of Breast Cancer: A Systematic Review and Two Meta-Analyses Based on Four Million Cases". , 2023, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[2] A. Jemal,et al. Cancer statistics, 2023 , 2023, CA: a cancer journal for clinicians.
[3] A. Jemal,et al. Breast Cancer Statistics, 2022 , 2022, CA: a cancer journal for clinicians.
[4] A. Jemal,et al. Cancer treatment and survivorship statistics, 2022 , 2022, CA: a cancer journal for clinicians.
[5] G. Che,et al. Primary Lung Cancer After Treatment for Breast Cancer , 2021, International journal of women's health.
[6] F. Cappuzzo,et al. Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis , 2021, Molecular diagnosis & therapy.
[7] David R. Jones,et al. Primary lung cancer in women after previous breast cancer , 2021, BJS open.
[8] Q. Wen,et al. Osimertinib for compound EGFR exon 19 deletion/T790M mutated lung squamous cell carcinoma , 2020, Thoracic cancer.
[9] M. Tiemann,et al. Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors , 2020, BMC Cancer.
[10] A. Fakhari,et al. Correlation of cancer antigen 15-3 (CA15-3) serum level and bony metastases in breast cancer patients , 2019, Medical journal of the Islamic Republic of Iran.
[11] N. Hulikal,et al. Metachronous Second Primary Malignancies in Known Breast Cancer Patients on 18F-Fluoro-2-Deoxyglucose Positron Emission Tomography–Computerized Tomography in a Tertiary Care Center , 2019, Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India.
[12] Y. Shu,et al. Second Primary Lung Cancer After Breast Cancer: A Population-Based Study of 6,269 Women , 2018, Front. Oncol..
[13] P. Malmström,et al. Long-term effects on the incidence of second primary cancers in a randomized trial of two and five years of adjuvant tamoxifen , 2017, Acta oncologica.
[14] S. Armato,et al. Clinical significance of noncalcified lung nodules in patients with breast cancer , 2016, Breast Cancer Research and Treatment.
[15] Christopher I. Li. Abstract ES5-2: Second primary cancers among breast cancer survivors: Incidence and risk factors , 2015 .
[16] A. Berrington de González,et al. The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status , 2012, Cancer Causes & Control.
[17] J. Stebbing,et al. The clinical significance of radiologically detected silent pulmonary nodules in early breast cancer. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[18] J. Siegfried,et al. Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects. , 2005, Cancer research.
[19] A. Dasgupta,et al. Diagnostic Role of Tumour Markers CEA, CA15-3, CA19-9 and CA125 in Lung Cancer , 2012, Indian Journal of Clinical Biochemistry.
[20] Matthew J Hayat,et al. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. , 2007, The oncologist.